Connection

Paolo Brambilla to Prognosis

Back to Details
This is a "connection" page, showing publications Paolo Brambilla has written about Prognosis.
Paolo Brambilla
Connection Strength
0.086
Prognosis
  1. Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual. Ann Rheum Dis. 2019 12; 78(12):1681-1685.
    View in: PubMed
    Score: 0.019
  2. Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study. Arthritis Care Res (Hoboken). 2018 08; 70(8):1218-1227.
    View in: PubMed
    Score: 0.017
  3. A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol. 2016 Aug; 35(8):2117-2123.
    View in: PubMed
    Score: 0.015
  4. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021 06 30; 31(7):2156-2164.
    View in: PubMed
    Score: 0.010
  5. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):68-75.
    View in: PubMed
    Score: 0.009
  6. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 11; 76(11):1897-1905.
    View in: PubMed
    Score: 0.008
  7. Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium. Eur Heart J. 2017 Aug 21; 38(32):2490-2498.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.